{"id":46542,"date":"2022-07-25T23:01:58","date_gmt":"2022-07-25T21:01:58","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-release-second-quarter-2022-financial-and-operational-results-on-august-4-2022\/"},"modified":"2022-07-25T23:01:58","modified_gmt":"2022-07-25T21:01:58","slug":"aurinia-pharmaceuticals-to-release-second-quarter-2022-financial-and-operational-results-on-august-4-2022","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-release-second-quarter-2022-financial-and-operational-results-on-august-4-2022\/","title":{"rendered":"Aurinia Pharmaceuticals to Release Second Quarter 2022 Financial and Operational Results on August 4, 2022"},"content":{"rendered":"
\n

VICTORIA, British Columbia & ROCKVILLE, Md.–(BUSINESS WIRE)–Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (\u201cAurinia\u201d or the \u201cCompany\u201d) today announced that it will release financial and operational results for the second quarter of 2022 on Thursday, August 4, 2022, before markets open. Aurinia\u2019s management team will host a conference call\/webcast at 8:30 am ET that day to review these results and provide a general business update.\n<\/p>\n

<\/a><\/p>\n

\nInterested participants can dial 877-407-9170<\/b> (Toll-free U.S. & Canada). The audio webcast can also be accessed under “News\/Events\u201d through the \u201cInvestors\u201d section of the Aurinia corporate website at www.auriniapharma.com<\/a>. A replay of the webcast will be available on Aurinia\u2019s website.\n<\/p>\n

\nAbout Aurinia<\/b>\n<\/p>\n

\nAurinia Pharmaceuticals is a fully integrated biopharmaceutical company focused on delivering therapies to treat targeted patient populations that are impacted by serious diseases with a high unmet medical need. In January 2021, the Company introduced LUPKYNIS\u00ae (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis (LN). The Company\u2019s head office is in Victoria, British Columbia, its U.S. commercial hub is in Rockville, Maryland, and the Company focuses its development efforts globally.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor and Corporate<\/b>
DeDe Sheel, VP, Investor Relations<\/b>
aurinia@westwicke.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

VICTORIA, British Columbia & ROCKVILLE, Md.–(BUSINESS WIRE)–Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (\u201cAurinia\u201d or the \u201cCompany\u201d) today announced that it will release financial and operational results for the second quarter of 2022 on Thursday, August 4, 2022, before markets open. Aurinia\u2019s management team will host a conference call\/webcast at 8:30 am ET that day to review … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46542","6":"format-standard","7":"category-industry"},"yoast_head":"\nAurinia Pharmaceuticals to Release Second Quarter 2022 Financial and Operational Results on August 4, 2022 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-release-second-quarter-2022-financial-and-operational-results-on-august-4-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aurinia Pharmaceuticals to Release Second Quarter 2022 Financial and Operational Results on August 4, 2022 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"VICTORIA, British Columbia & ROCKVILLE, Md.–(BUSINESS WIRE)–Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (\u201cAurinia\u201d or the \u201cCompany\u201d) today announced that it will release financial and operational results for the second quarter of 2022 on Thursday, August 4, 2022, before markets open. Aurinia\u2019s management team will host a conference call\/webcast at 8:30 am ET that day to review ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-release-second-quarter-2022-financial-and-operational-results-on-august-4-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-25T21:01:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220725005597\/en\/787478\/21\/Aurinia-Logo-RBG-031620-v01.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aurinia-pharmaceuticals-to-release-second-quarter-2022-financial-and-operational-results-on-august-4-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aurinia-pharmaceuticals-to-release-second-quarter-2022-financial-and-operational-results-on-august-4-2022\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Aurinia Pharmaceuticals to Release Second Quarter 2022 Financial and Operational Results on August 4, 2022\",\"datePublished\":\"2022-07-25T21:01:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aurinia-pharmaceuticals-to-release-second-quarter-2022-financial-and-operational-results-on-august-4-2022\\\/\"},\"wordCount\":215,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aurinia-pharmaceuticals-to-release-second-quarter-2022-financial-and-operational-results-on-august-4-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220725005597\\\/en\\\/787478\\\/21\\\/Aurinia-Logo-RBG-031620-v01.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aurinia-pharmaceuticals-to-release-second-quarter-2022-financial-and-operational-results-on-august-4-2022\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aurinia-pharmaceuticals-to-release-second-quarter-2022-financial-and-operational-results-on-august-4-2022\\\/\",\"name\":\"Aurinia Pharmaceuticals to Release Second Quarter 2022 Financial and Operational Results on August 4, 2022 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aurinia-pharmaceuticals-to-release-second-quarter-2022-financial-and-operational-results-on-august-4-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aurinia-pharmaceuticals-to-release-second-quarter-2022-financial-and-operational-results-on-august-4-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220725005597\\\/en\\\/787478\\\/21\\\/Aurinia-Logo-RBG-031620-v01.jpg\",\"datePublished\":\"2022-07-25T21:01:58+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aurinia-pharmaceuticals-to-release-second-quarter-2022-financial-and-operational-results-on-august-4-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aurinia-pharmaceuticals-to-release-second-quarter-2022-financial-and-operational-results-on-august-4-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aurinia-pharmaceuticals-to-release-second-quarter-2022-financial-and-operational-results-on-august-4-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220725005597\\\/en\\\/787478\\\/21\\\/Aurinia-Logo-RBG-031620-v01.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220725005597\\\/en\\\/787478\\\/21\\\/Aurinia-Logo-RBG-031620-v01.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aurinia-pharmaceuticals-to-release-second-quarter-2022-financial-and-operational-results-on-august-4-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aurinia Pharmaceuticals to Release Second Quarter 2022 Financial and Operational Results on August 4, 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aurinia Pharmaceuticals to Release Second Quarter 2022 Financial and Operational Results on August 4, 2022 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-release-second-quarter-2022-financial-and-operational-results-on-august-4-2022\/","og_locale":"en_US","og_type":"article","og_title":"Aurinia Pharmaceuticals to Release Second Quarter 2022 Financial and Operational Results on August 4, 2022 - Pharma Trend","og_description":"VICTORIA, British Columbia & ROCKVILLE, Md.–(BUSINESS WIRE)–Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (\u201cAurinia\u201d or the \u201cCompany\u201d) today announced that it will release financial and operational results for the second quarter of 2022 on Thursday, August 4, 2022, before markets open. Aurinia\u2019s management team will host a conference call\/webcast at 8:30 am ET that day to review ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-release-second-quarter-2022-financial-and-operational-results-on-august-4-2022\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-25T21:01:58+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220725005597\/en\/787478\/21\/Aurinia-Logo-RBG-031620-v01.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-release-second-quarter-2022-financial-and-operational-results-on-august-4-2022\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-release-second-quarter-2022-financial-and-operational-results-on-august-4-2022\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Aurinia Pharmaceuticals to Release Second Quarter 2022 Financial and Operational Results on August 4, 2022","datePublished":"2022-07-25T21:01:58+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-release-second-quarter-2022-financial-and-operational-results-on-august-4-2022\/"},"wordCount":215,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-release-second-quarter-2022-financial-and-operational-results-on-august-4-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220725005597\/en\/787478\/21\/Aurinia-Logo-RBG-031620-v01.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-release-second-quarter-2022-financial-and-operational-results-on-august-4-2022\/","url":"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-release-second-quarter-2022-financial-and-operational-results-on-august-4-2022\/","name":"Aurinia Pharmaceuticals to Release Second Quarter 2022 Financial and Operational Results on August 4, 2022 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-release-second-quarter-2022-financial-and-operational-results-on-august-4-2022\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-release-second-quarter-2022-financial-and-operational-results-on-august-4-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220725005597\/en\/787478\/21\/Aurinia-Logo-RBG-031620-v01.jpg","datePublished":"2022-07-25T21:01:58+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-release-second-quarter-2022-financial-and-operational-results-on-august-4-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-release-second-quarter-2022-financial-and-operational-results-on-august-4-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-release-second-quarter-2022-financial-and-operational-results-on-august-4-2022\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220725005597\/en\/787478\/21\/Aurinia-Logo-RBG-031620-v01.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220725005597\/en\/787478\/21\/Aurinia-Logo-RBG-031620-v01.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-release-second-quarter-2022-financial-and-operational-results-on-august-4-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Aurinia Pharmaceuticals to Release Second Quarter 2022 Financial and Operational Results on August 4, 2022"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46542","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46542"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46542\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46542"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46542"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46542"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}